14158 Results (Page 440 of 567)
All Market Research Reports
UAE Healthcare Claims Management Market Analysis
The UAE healthcare claims management market is projected to grow from $133.5 Mn in 2022 to $765.67 Mn by 2030, registering a CAGR of 24.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be mandatory health insurance, emphasis on quality healthcare and technological advancements. The market is segmented by component, type, delivery mode and by end-user. Some of the major players include NAS Neuron Health Services, Nextcare, Aafiya, Optum, GE Healthcare and Cognizant.
India Healthcare Claims Management Market Analysis
The India healthcare claims management market is projected to grow from $485.57 Mn in 2022 to $3163.92 Mn by 2030, registering a CAGR of 26.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be growing health insurance penetration, increasing adoption of digital technology, rising healthcare frauds and government initiatives. The market is segmented by component, type, delivery mode and by end-user. Some of the major players include Wipro, Infosys, Tech Mahindra, Accenture and eClinicalWorks.
South Korea Oncology Clinical Trials Market Analysis
South Korea's oncology clinical trials market is projected to grow from $184.8 Mn in 2022 to $305.9 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. The market will be driven by the country's well-established infrastructure, advanced medical facilities, and streamlined regulatory processes. The market is segmented by phase, study design, and indication. Some of the major players include Pfizer Inc., Roche Holding AG & SK Biopharmaceuticals.
China Healthcare Claims Management Market Analysis
The China healthcare claims management market is projected to grow from $2.15 Bn in 2022 to $12.71 Bn by 2030, registering a CAGR of 24.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be the growing adoption of digital healthcare, increasing healthcare fraud, government initiatives and increasing healthcare spending. The market is segmented by component, type, delivery mode and by end-user. Some of the major players include Ping a Healthcare, China Pacific Insurance, Cognizant, Allianz and Cigna.
Brazil Healthcare Claims Management Market Analysis
The Brazil healthcare claims management market is projected to grow from $667.5 Mn in 2022 to $3828.37 Mn by 2030, registering a CAGR of 24.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be increased adoption of value-based care, increasing demand for healthcare services, government initiatives and rising healthcare costs. The market is segmented by component, type, delivery mode and by end-user. Some of the major players include Bradesco Saude, Sinistro Facil, Amil, DXC Technology, Accenture and Cognizant.
Australia Healthcare Claims Management Market Analysis
The Australian healthcare claims management market is projected to grow from $320.4 Mn in 2022 to $1897.54 Mn by 2030, registering a CAGR of 24.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be an increase in healthcare provider consolidation, technological advancements, regulatory changes and an increase in healthcare spending. The market is segmented by component, type, by delivery mode and end-user. Some of the major players include Proclaim, Medibank, Riskware, Cognizant and Accenture.
Saudi Arabia Oncology Clinical Trials Market Analysis
Saudi Arabia's Oncology Clinical Trials Market is projected to grow from $215.1 Mn in 2022 to $369.5 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022-30. The market will be driven by the need for improved cancer treatment alternatives and the rise in collaborations between Saudi Arabian research institutes and foreign organizations. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Roche Holding AG & Tabuk Pharmaceuticals.
Vietnam Healthcare Insurance Market Analysis
The Vietnam healthcare insurance market is projected to grow from $10.13 Bn in 2022 to $18.52 Bn by 2030, registering a CAGR of 7.83% during the forecast period of 2022 - 2030. The main factors driving the growth would be economic growth, rising middle class, urbanization and government investment. The market is segmented by component, the provider, coverage, by health insurance plans and end-user. Some of the major players include Bao Viet, PetroVietnam Insurance, Dai-ichi Life, AIA and Manulife.
Thailand Healthcare Insurance Market Analysis
The Thailand healthcare insurance market is projected to grow from $2.43 Bn in 2022 to $4.48 Bn by 2030, registering a CAGR of 7.94% during the forecast period of 2022 - 2030. The main factors driving the growth would be medical tourism, technological advancements, rising incomes and an increasing geriatric population. The market is segmented by component, the provider, coverage, by health insurance plans and end-user. Some of the major players include Thaivivat, Navakij, Dhipaya, Bupa and AXA.
US Diabetes Devices Market Analysis
The US diabetes devices market is projected to grow from $4.7 Bn in 2022 to $5.9 Bn by 2030, registering a CAGR of 2.75% during the forecast period of 2022-30. Some of the key trends in the US diabetes devices market include the development of more advanced glucose monitoring and insulin delivery technologies, the use of digital health platforms and apps to help patients manage their diabetes, and the shift towards value-based care models that prioritize patient outcomes and cost-effectiveness. The US diabetes devices market is highly competitive, with several major players dominating the market. Some of the key players in the market include Abbott Laboratories, Medtronic, Dexcom, Roche, and Insulet Corporation.
US Healthcare Financial Analytics Market Analysis
The US Healthcare Financial Analytics market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4.8% from 2022 to 2030 and will reach $xx Bn in 2030. The market is segmented by type, component, and deployment. The US Healthcare Financial Analytics market will grow due to adoption of electronic health records (EHRs). The key market players are OptumInsight, McKesson Corporation, Cerner Corporation, IBM Corporation, and others.
Poland Oncology Clinical Trials Market Analysis
Poland's oncology clinical trials market is projected to grow from $73.4 Mn in 2022 to $116.5 Mn by 2030, registering a CAGR of 5.95% during the forecast period of 2022-30. The market will be driven by the increased prevalence of cancer and a good regulatory framework. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Roche Holding AG, Novartis International AG & Ryvu Therapeutics.
US Cardiac Surgery Instruments Market Analysis
The US cardiac surgery instruments market is projected to grow from $0.9 Bn in 2022 to $1.2 Bn by 2030, registering a CAGR of 4.6% during the forecast period of 2022-30. This growth is primarily due to an increasing number of cardiac surgeries, especially in the elderly population, and the adoption of advanced surgical instruments. The market is highly competitive, with several established players including B. Braun Melsungen AG, CONMED Corporation, Johnson & Johnson Services, Inc., Medline Industries, Inc., and Stryker Corporation. These companies offer a wide range of cardiac surgery instruments and compete on the basis of product quality, innovation, and pricing.
Italy Healthcare Financial Analytics Market Analysis
The Italy Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.3% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. Italy’s Healthcare Financial Analytics market will grow as the demand for data-driven decision-making is rising, and financial analytics. The key market players are IBM Watson Health, Zucchetti Group, Optum Italia, Oracle Italia, SAS Institute Italiaand others.
Turkey Oncology Clinical Trials Market Analysis
Turkey's oncology clinical trials market is projected to grow from $101.2 Mn in 2022 to $161.3 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The market will be driven by the country's expanding healthcare infrastructure and increased emphasis on R&D. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Roche Holding AG & Deva Holding.
Tanzania Oncology Clinical Trials Market Analysis
Tanzania's oncology clinical trials market is projected to grow from $5.06 Mn in 2022 to $8.31 Mn by 2030, registering a CAGR of 6.4% during the forecast period of 2022-30. The market will be driven by the country's high cancer burden and its rising expenditure on research and development. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Roche Holding AG & Novartis International AG.
UK Healthcare Financial Analytics Market Analysis
The UK Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4.8% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. UK’s Healthcare Financial Analytics market will grow the adoption of EHRs has been increasing in the UK healthcare sector. Financial analytics solutions can integrate with EHRs to provide a comprehensive view of a patient's health history and enable better decision-making. The key market players are Draper & Dash, MedeAnalytics, Informatics Merseyside, EY, and others.
Canada Healthcare Financial Analytics Market Analysis
The Canada Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.8% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. Canada’s Healthcare Financial Analytics market will grow as the rising cost of healthcare in Canada is driving the need for financial analytics solutions that can help healthcare organizations manage and optimize their spending. The key market players are IBM Watson Health, Healthtech Consultants, MedeAnalytics, McKesson, and others.
Vietnam ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Vietnam's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to witness growth from $148 Mn in 2022 to $268 Mn in 2030 with a CAGR of 7.73% for the year 2022-30. The rise in urbanization in Vietnam leading to the increased incidence of ADHD among the school-going population and increasing investments in the healthcare infrastructure are the major market drivers. The Vietnam ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. ImexPharm Pharmaceutical, Binh Dinh Pharmaceutical, and Eli Lily are the leading players in the market.
UAE ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
UAE's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $148 Mn in 2022 to $284 Mn in 2030 with a CAGR of 8.5% for the year 2022-30. More cases of ADHD being diagnosed in children and UAE and the development of health infrastructure in UAE are the main market drivers. The UAE ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Join Hub Gulf Pharma, Genpharm, and Eli Lilly are some of the key players in the market.
Thailand ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Thailand's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to witness growth from $35 Mn in 2022 to $65 Mn in 2030 with a CAGR of 7.84% for the year 2022-30. The increase in the disposable incomes of the population in Thailand and the rising demand for effective treatment options for ADHD in Thailand are propelling the market growth. The Thailand ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the leading companies in the market are Healol Pharmaceuticals, Sriprasit Pharmacy, and Prude Pharma.
UAE Healthcare Financial Analytics Market Analysis
The UAE Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.8% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. UAE’s Healthcare Financial Analytics market will grow as rising healthcare costs, increasing demand for better patient outcomes, and the growing adoption of digital technologies in healthcare. The key market players are Healthbit, Pulsus Healthtech, Fórmula Médica, Kryptus, and others.
Philippines ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Philippines Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to witness growth from $65 Mn in 2022 to $120 Mn in 2030 with a CAGR of 8% for the year 2022-30. The increase in ADHD awareness in the Philippines as a result of various government initiatives to spearhead information about ADHD is the major growth driver of the market. The Philippines ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Farmacia Medica, Phil Pharmawealth, and Eli Lily are some of the key players in the market.
Singapore Healthcare Insurance Market Analysis
The Singapore healthcare insurance market is projected to grow from $2.43 Bn in 2022 to $4.57 Bn by 2030, registering a CAGR of 8.2% during the forecast period of 2022 - 2030. The main factors driving the growth would be a strong economy, government support, technological advancements and an ageing population. The market is segmented by the component, provider, coverage, by health insurance plans and end-user. Some of the major players include NTUC Income, Great Eastern, AIA, AXA and Prudential.
Singapore 3D Printing Medical Devices Market Analysis
Singapore 3D Printing Medical Device Market is expected to witness growth from $4 Mn in 2022 to $12 Mn in 2030 with a CAGR of 16.90% for the forecasted year 2022-2030. In Singapore, the demand for 3D Printing Medical devices is being driven by Singapore's ageing population. The market is segmented by application, by technology and by end user. Some key players in this market include: Creatz3D, GE Healthcare, Stryker, Medtronic, Structo and Siemens Healthineers.
